The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aranda Investments Pte Ltd
NIVABUPA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aranda Investments Pte Ltd, a Singapore-based investor (not part of the promoter group), purchased 70,000 equity shares of Niva Bupa Health Insurance Company Ltd through the open market on February 5, 2026. Along with persons acting in concert (V-Sciences Investments Pte Ltd and Zulia Investments Pte. Ltd.), their collective shareholding rose from 4.9968% (92,30,09,75 shares) to 5.0006% (92,37,09,75 shares), crossing the 5% disclosure threshold under SEBI takeover rules. This triggered the mandatory Regulation 29(1) disclosure. The acquisition is small in absolute terms but significant because it nudges the investor past the regulatory reporting threshold.
This is a routine disclosure triggered by crossing the 5% mark — it does not indicate any change in promoter control. However, it signals continued interest from a foreign institutional investor in Niva Bupa, which could be mildly positive for sentiment as it suggests confidence from sophisticated global investors.